CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
-6.85%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-8.5%)
Cap. Flow
+$903K
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10
Top Buys
| 1 |
CVS Health
CVS
|
$1.77M |
| 2 |
Baidu
BIDU
|
$1.3M |
| 3 |
Cohu
COHU
|
$993K |
| 4 |
First Financial Corporation Common Stock
THFF
|
$959K |
| 5 |
Talos Energy
TALO
|
$911K |
Top Sells
| 1 |
American Superconductor
AMSC
|
$3.38M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
$2.96M |
| 3 |
Incyte
INCY
|
$1.71M |
| 4 |
First Horizon
FHN
|
$1.54M |
| 5 |
Tejon Ranch
TRC
|
$693K |
Sector Composition
| 1 | Healthcare | 35.69% |
| 2 | Technology | 11.09% |
| 3 | Materials | 10.64% |
| 4 | Consumer Staples | 8.17% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CVS Health
CVS
$92.8B
| $1.77M | 1.63% | +30,000 | New | +$1.77M |
|
27
Evolus
EOLS
$494M
| $1.63M | 1.49% | 150,000 | – | – |
|
28
Sabre
SABR
$706M
| $1.6M | 1.47% | 600,000 +100,000 | +20% | +$267K |
|
29
Brookline Bancorp
BRKL
$976M
| $1.59M | 1.46% | 190,000 +10,000 | +6% | +$83.5K |
|
|
SVC
30
Service Properties Trust
SVC
$451M
| $1.54M | 1.41% | 300,000 | – | – |
|
31
Pan American Silver
PAAS
$12.3B
| $1.49M | 1.37% | 75,000 -25,000 | -25% | -$497K |
|
32
Warner Bros
WBD
$28.8B
| $1.49M | 1.37% | 200,000 | – | – |
|
|
33
First Financial Corporation Common Stock
THFF
$699M
| $1.48M | 1.35% | 40,000 +26,000 | +186% | +$959K |
|
34
Pfizer
PFE
$141B
| $1.4M | 1.28% | 50,000 | – | – |
|
35
Jazz Pharmaceuticals
JAZZ
$7.75B
| $1.33M | 1.22% | 12,500 | – | – |
|
36
Xoma
XOMA
$392M
| $1.3M | 1.2% | 55,000 | – | – |
|
37
AMCON Distributing
DIT
$77.4M
| $1.15M | 1.06% | 8,200 +200 | +3% | +$28.1K |
|
38
Newell Brands
NWL
$2.48B
| $1.12M | 1.03% | 175,000 | – | – |
|
39
Heron Therapeutics
HRTX
$207M
| $1.05M | 0.96% | 300,000 | – | – |
|
|
RVNC
40
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.03M | 0.94% | 400,000 +150,000 | +60% | +$386K |
|
|
41
Cohu
COHU
$929M
| $993K | 0.91% | +30,000 | New | +$993K |
|
42
Nektar Therapeutics
NKTR
$568M
| $930K | 0.85% | 750,000 -189,847 | -20% | -$235K |
|
43
Atea Pharmaceuticals
AVIR
$267M
| $894K | 0.82% | 270,000 | – | – |
|
44
Hasbro
HAS
$11.4B
| $878K | 0.81% | +15,000 | New | +$878K |
|
45
Curis
CRIS
$20.9M
| $828K | 0.76% | 120,000 | – | – |
|
46
Kraft Heinz
KHC
$33.1B
| $806K | 0.74% | +25,000 | New | +$806K |
|
47
Park Hotels & Resorts
PK
$2.35B
| $749K | 0.69% | 50,000 | – | – |
|
48
Acadia Pharmaceuticals
ACAD
$4.38B
| $650K | 0.6% | 40,000 | – | – |
|
49
Coya Therapeutics
COYA
$110M
| $606K | 0.56% | 100,000 | – | – |
|
50
Cytosorbents Corp
CTSO
$59.2M
| $598K | 0.55% | 850,000 +25,000 | +3% | +$17.6K |
|